To determine the association between ER-DEGs and overall survival of patients with HER2+ BC, we performed the univariate Cox regression in the subgroup of HER2+ BC from TCGA-BRCA and discovered that 9 of the 42 ER-DEGs were associated with clinical prognosis (p < 0.1). Here, ERBB2 is linked to breast cancer.